The $100,000 grant from Brain Cancer Canada will allow McMaster scientist Sheila Singh to devise new treatments for recurrent glioblastomas.
Brain cancer in children is always a devastating diagnosis, but McMaster researchers may have found a way to have the most serious types of pediatric brain cancer respond better to therapies.
McMaster start-up Empirica Therapeutics has been acquired by Philadelphia-based Century Therapeutics, a leader in curative cell therapies for cancer. Now known as Century Therapeutics Canada, the new subsidiary will be based at McMaster Innovation Park.
McMaster logo
McMaster logo
